The effects of centrally acting ACE inhibitors on the rate of cognitive and functional decline in dementia: a KDD approach
dc.check.embargoformat | Not applicable | en |
dc.check.info | No embargo required | en |
dc.check.opt-out | No | en |
dc.check.reason | No embargo required | en |
dc.check.type | No Embargo Required | |
dc.contributor.advisor | Molloy, D. William | en |
dc.contributor.advisor | Sammon, David | en |
dc.contributor.author | Gao, Yang | |
dc.date.accessioned | 2016-05-25T16:39:10Z | |
dc.date.available | 2016-05-25T16:39:10Z | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014 | |
dc.description.abstract | Alzheimer’s Disease and other dementias are one of the most challenging illnesses confronting countries with ageing populations. Treatment options for dementia are limited, and the costs are significant. There is a growing need to develop new treatments for dementia, especially for the elderly. There is also growing evidence that centrally acting angiotensin converting enzyme (ACE) inhibitors, which cross the blood-brain barrier, are associated with a reduced rate of cognitive and functional decline in dementia, especially in Alzheimer’s disease (AD). The aim of this research is to investigate the effects of centrally acting ACE inhibitors (CACE-Is) on the rate of cognitive and functional decline in dementia, using a three phased KDD process. KDD, as a scientific way to process and analysis clinical data, is used to find useful insights from a variety of clinical databases. The data used are from three clinic databases: Geriatric Assessment Tool (GAT), the Doxycycline and Rifampin for Alzheimer’s Disease (DARAD), and the Qmci validation databases, which were derived from several different geriatric clinics in Canada. This research involves patients diagnosed with AD, vascular or mixed dementia only. Patients were included if baseline and end-point (at least six months apart) Standardised Mini-Mental State Examination (SMMSE), Quick Mild Cognitive Impairment (Qmci) or Activities Daily Living (ADL) scores were available. Basically, the rates of change are compared between patients taking CACE-Is, and those not currently treated with CACE-Is. The results suggest that there is a statistically significant difference in the rate of decline in cognitive and functional scores between CACE-I and NoCACE-I patients. This research also validates that the Qmci, a new short assessment test, has potential to replace the current popular screening tests for cognition in the clinic and clinical trials. | en |
dc.description.status | Not peer reviewed | en |
dc.description.version | Accepted Version | |
dc.format.mimetype | application/pdf | en |
dc.identifier.citation | Gao, Y. 2014. The effects of centrally acting ACE inhibitors on the rate of cognitive and functional decline in dementia: a KDD approach. PhD Thesis, University College Cork. | en |
dc.identifier.endpage | 280 | en |
dc.identifier.uri | https://hdl.handle.net/10468/2626 | |
dc.language.iso | en | en |
dc.publisher | University College Cork | en |
dc.rights | © 2014, Yang Gao. | en |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/ | en |
dc.subject | Dementia | en |
dc.subject | Alzheimer’s disease | en |
dc.subject | Centrally acting angiotensin converting enzyme inhibitors | en |
dc.subject | Knowledge discovery | en |
dc.subject | Data analysis | en |
dc.subject | Qmci | en |
dc.thesis.opt-out | true | |
dc.title | The effects of centrally acting ACE inhibitors on the rate of cognitive and functional decline in dementia: a KDD approach | en |
dc.type | Doctoral thesis | en |
dc.type.qualificationlevel | Doctoral | en |
dc.type.qualificationname | PHD (Business Information Systems) | en |
ucc.workflow.supervisor | w.molloy@ucc.ie |
Files
Original bundle
1 - 2 of 2
Loading...
- Name:
- Abstract.pdf
- Size:
- 9.38 KB
- Format:
- Adobe Portable Document Format
- Description:
- Abstract
Loading...
- Name:
- Yang thesis_final.pdf
- Size:
- 8.25 MB
- Format:
- Adobe Portable Document Format
- Description:
- Full Text E-thesis
License bundle
1 - 1 of 1
Loading...
- Name:
- license.txt
- Size:
- 5.62 KB
- Format:
- Item-specific license agreed upon to submission
- Description: